| Literature DB >> 25691910 |
Fang-Hao Zheng1, Ping Wei1, Hui-Ling Huo1, Xue-Feng Xing2, Fei-Long Chen2, Xiao-Mei Tan2, Jia-Bo Luo2.
Abstract
Herb Ephedra (Ma Huang in Chinese) and Ramulus Cinnamomi (Gui Zhi in Chinese) are traditional Chinese herbs, often used together to treat asthma, nose and lung congestion, and fever with anhidrosis. Due to the adverse effects of ephedrine, clinical use of Ma Huang is restricted. However, Gui Zhi extract has been reported to decrease spontaneous activity in rats and exert anti-inflammatory and neuroprotective effects. The present study explored the possible inhibitory effect of Gui Zhi on Ma Huang-induced neurotoxicity in rats when the two herbs were used in combination. All Ma Huang and Ma Huang-Gui Zhi herb pair extracts were prepared using methods of traditional Chinese medicine and were normalized based on the ephedrine content. Two-month-old male Sprague-Dawley rats (n = 6 rats/group) were administered Ma Huang or the Ma Huang-Gui Zhi herb pair extracts for 7 days (ephedrine = 48 mg/kg), and locomotor activity was measured. After 7 days, oxidative damage in the prefrontal cortex was measured. Gui Zhi decreased hyperactivity and sensitization produced by repeated Ma Huang administration and attenuated oxidative stress induced by Ma Huang. The results of this study demonstrate the neuroprotective potential of Gui Zhi in Ma Huang-induced hyperactivity and oxidative damage in the prefrontal cortex of rats when used in combination.Entities:
Year: 2015 PMID: 25691910 PMCID: PMC4321680 DOI: 10.1155/2015/913461
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1The HPLC profiles of ephedrine in standard solution (a) and typical extracts containing Ma Huang (b). A: (−)-ephedrine.
Figure 2The ephedrine content of the Ma Huang and Ma Huang-Gui Zhi herb pair extracts. The values are the means ± SEM obtained from three replicate injections. * P < 0.05, ** P < 0.01 as compared to E.
Ma Huang or Ma Huang-Gui Zhi herb pair extracts and the adjusted concentration.
| Sample | Composition | Ephedrine (mg/mL) | Ephedra (g/mL) |
|---|---|---|---|
| E | Ma Huang | 4.8 | 1.50 |
| W1 | 3 : 1 (Ma Huang-Gui Zhi) | 4.8 | 1.58 |
| W2 | 3 : 2 (Ma Huang-Gui Zhi) | 4.8 | 1.85 |
| W3 | 3 : 4 (Ma Huang-Gui Zhi) | 4.8 | 2.32 |
Effects of acute intragastric administration in the OF test.
| Group | Zone | Time (s) | P. time (%) | Crossing | Rearing | Distance traveled (m) |
|---|---|---|---|---|---|---|
| Saline | 1 | 245.40 ± 17.11# | 81.80 ± 5.70# | 15.50 ± 1.87# | 23.17 ± 6.31# | 22.39 ± 1.74# |
| 2 | 43.77 ± 24.11 | 14.59 ± 8.04 | ||||
| 3 | 5.40 ± 3.84 | 1.80 ± 1.20 | ||||
|
| ||||||
| E | 1 | 284.62 ± 4.62* | 94.87 ± 1.54* | 11.00 ± 3.58* | 8.00 ± 3.46* | 31.66 ± 1.48* |
| 2 | 14.98 ± 4.54 | 4.99 ± 1.51 | ||||
| 3 | 0.23 ± 0.48 | 0.08 ± 0.16 | ||||
|
| ||||||
| W1 | 1 | 289.23 ± 8.47* | 96.41 ± 2.82* | 12.83 ± 2.48 | 13.50 ± 4.51∗# | 28.42 ± 2.49∗# |
| 2 | 8.63 ± 6.02 | 2.88 ± 2.01 | ||||
| 3 | 1.97 ± 2.76 | 0.66 ± 0.92 | ||||
|
| ||||||
| W2 | 1 | 272.92 ± 3.95# | 90.97 ± 1.32# | 14.33 ± 2.42# | 17.00 ± 3.03∗# | 25.34 ± 2.37∗# |
| 2 | 17.85 ± 3.17 | 5.95 ± 1.06 | ||||
| 3 | 3.47 ± 3.18 | 1.16 ± 1.06 | ||||
|
| ||||||
| W3 | 1 | 250.75 ± 15.22# | 83.58 ± 5.07# | 15.17 ± 1.94# | 20.33 ± 1.75# | 20.85 ± 0.93# |
| 2 | 43.02 ± 16.23# | 14.34 ± 5.41# | ||||
| 3 | 4.30 ± 2.05# | 1.43 ± 0.69# | ||||
* P < 0.05 indicates a significant difference compared to the saline treated group; # P < 0.05 indicates a significant difference compared to the E-treated group.
Figure 3The effects of repeated Ma Huang and Ma Huang-Gui Zhi administration on locomotor activity. The data represents the mean ± SEM of six rats. * P < 0.05 indicates a significant difference compared to the saline treated group at each time point. # P < 0.05 indicates a significant difference compared to the corresponding group on day 1.
Figure 4Each bar represents the mean ± SEM of six rats. * P < 0.05, ** P < 0.01 indicates a significant difference compared to the saline treated group; # P < 0.05, ## P < 0.01 indicates a significant difference compared to E-treated rats (ANOVA).